AI assistant
AMGEN INC — Director's Dealing 2012
May 1, 2012
29819_dirs_2012-05-01_034edcfa-223a-4cd9-a3cd-8b7233bb32a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-04-27
Reporting Person: HOOPER ANTHONY C (EVP, Global Commercial Ops.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-04-27 | Common Stock | A | 8654 | — | Acquired | 67227 | Direct |
Footnotes
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.
F2: These shares include the following RSUs granted under the Company's equity plans: 17,753 RSUs which vest in one installment of 8,744 on 3/2/2013 and one installment of 9,009 on 3/2/2014; 22,619 RSUs which vest in two equal annual installments of 7,690 each on 3/2/2013 and 3/2/2014 and one installment of 7,239 on 3/2/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.